U.S. Markets open in 2 hrs 8 mins
  • S&P Futures

    4,585.50
    +14.25 (+0.31%)
     
  • Dow Futures

    35,342.00
    +83.00 (+0.24%)
     
  • Nasdaq Futures

    15,269.25
    +63.25 (+0.42%)
     
  • Russell 2000 Futures

    2,100.20
    +8.10 (+0.39%)
     
  • Crude Oil

    86.56
    +1.13 (+1.32%)
     
  • Gold

    1,817.30
    +4.90 (+0.27%)
     
  • Silver

    23.79
    +0.30 (+1.27%)
     
  • EUR/USD

    1.1348
    +0.0018 (+0.1589%)
     
  • 10-Yr Bond

    1.8650
    0.0000 (0.00%)
     
  • Vix

    22.00
    +2.81 (+14.64%)
     
  • GBP/USD

    1.3629
    +0.0030 (+0.2221%)
     
  • USD/JPY

    114.4540
    -0.1310 (-0.1143%)
     
  • BTC-USD

    42,108.36
    +350.62 (+0.84%)
     
  • CMC Crypto 200

    998.97
    -10.42 (-1.03%)
     
  • FTSE 100

    7,591.41
    +27.86 (+0.37%)
     
  • Nikkei 225

    27,467.23
    -790.02 (-2.80%)
     

LAWSUITS FILED AGAINST ATNX, SOS and EBON - Jakubowitz Law Pursues Shareholders Claims

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / April 29, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.

Athenex, Inc. (NASDAQ:ATNX)

CONTACT JAKUBOWITZ ABOUT ATNX:
https://claimyourloss.com/securities/athenex-inc-loss-submission-form/?id=15317&from=1

Class Period : August 7, 2019 - February 26, 2021

Lead Plaintiff Deadline : May 3, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the data included in the Oral Paclitaxel plus Encequidar NDA presented a safety risk to patients in terms of an increase in neutropenia-related sequalae; (ii) the uncertainty over the results of the primary endpoint of objective response rate (ORR) at week 19 conducted by BICR; (iii) the BICR reconciliation and re-read process may have introduced unmeasured bias and influence on the BICR; (iv) the Company's Phase 3 study that was used to file the NDA was inadequate and not well-conducted in a patient population with metastatic breast cancer representative of the U.S. population, such that the FDA would recommended a new such clinical trial; (v) as a result, it was foreseeable that the FDA would not approve the Company's NDA in its current form; and (vi) as a result, the Company's public statements were materially false and misleading at all relevant times.

SOS Limited (NYSE:SOS)

CONTACT JAKUBOWITZ ABOUT SOS:
https://claimyourloss.com/securities/sos-limited-loss-submission-form/?id=15317&from=1

Class Period : July 22, 2020 - February 25, 2021

Lead Plaintiff Deadline : June 1, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) SOS had misrepresented the true nature, location, and/or existence of at least one of the principal executive offices listed in its SEC filings; (ii) HY and FXK were either undisclosed related parties and/or entities fabricated by the Company; (iii) the Company had misrepresented the type and/or existence of the mining rigs that it claimed to have purchased; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Ebang International Holdings Inc. (NASDAQ:EBON)

CONTACT JAKUBOWITZ ABOUT EBON:
https://claimyourloss.com/securities/ebang-international-holdings-inc-loss-submission-form/?id=15317&from=1

Class Period : June 26, 2020 - April 5, 2021

Lead Plaintiff Deadline : June 7, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the proceeds from Ebang's public offerings had been directed to an low yield, long term bonds to an underwriter and to related parties rather than used to develop the Company's operations; (2) Ebang's sales were declining and the Company had inflated reported sales, including through the sale of defective units; (3) Ebang's attempts to go public in Hong Kong had failed due to allegations of embezzling investor funds and inflated sales figures; (4) Ebang's purported crytocurrency exchange was merely the purchase of an out-of-the-box crypto exchange; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887

SOURCE: Jakubowitz Law



View source version on accesswire.com:
https://www.accesswire.com/643426/LAWSUITS-FILED-AGAINST-ATNX-SOS-and-EBON--Jakubowitz-Law-Pursues-Shareholders-Claims